Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
about
MIA is a potential biomarker for tumour load in neurofibromatosis type 1NMF-mGPU: non-negative matrix factorization on multi-GPU systemsMolecular mechanisms promoting the pathogenesis of Schwann cell neoplasmsPPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signalingInhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis.MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.Epidemiology and therapies for metastatic sarcomaComparative methylome analysis of benign and malignant peripheral nerve sheath tumors.Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cellsSurvivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).The versatile functions of Sox9 in development, stem cells, and human diseasesRegulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine.Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT.Temporal Analysis of Gene Expression in the Murine Schwann Cell Lineage and the Acutely Injured Postnatal Nerve.Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform NeurofibromaLoss of tumor suppressor NF1 activates HSF1 to promote carcinogenesisRunx1 contributes to neurofibromatosis type 1 neurofibroma formation.Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumorsMEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cellsRole of LRF/Pokemon in lineage fate decisions.Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceMolecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-cateninAn inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous systemPathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problemsThe SOX family of genes in cancer development: biological relevance and opportunities for therapy.Neurofibromatosis type 1: diagnosis and recent advances.Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.Telomere erosion in NF1 tumorigenesis.Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.Neurofibromatosis and lessons for the war on cancer.Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.
P2860
Q21245252-C6FB872C-ABAD-4148-AD19-39EC1FF4F41FQ28649462-14D9B0D7-B412-4802-AF9B-3C5303873C05Q30457681-21C39CF8-D694-4802-BEFA-4AF1ED256867Q33594693-F2977155-A658-4CA6-9459-58EC14F23E20Q33604218-F2040913-B23D-45FA-82C2-03BBB2C0EE85Q33650336-CA4DD83F-1520-4F67-B940-78AD31A851C3Q34022861-EA05B1C8-3110-4FAD-9858-C6A291E84AD5Q34488339-B57B3755-E6B0-48B9-B0FE-DB9320D5F3BBQ34652142-E1A04D98-94DC-4710-B183-97CF80DB0E8EQ34729614-3F60370C-96F8-43C4-94D6-375038A38E26Q34979170-332825D2-FF05-473E-9333-ADD633CD789FQ35058504-A885F9C8-106E-45B7-8982-B46DBD4BB569Q35077784-85D6B4B8-732A-4757-9A84-5E3DEE92FA52Q35675222-93DAAB91-AFDB-4A07-B545-B62E5EE59731Q35686940-DFB5789D-F420-4984-A481-894DDECFD252Q35822579-DE898BA0-BEF0-4CBD-BAE9-3A7181585272Q35857307-CBC11E3A-1999-406E-AAB8-2DCE43DA9B9AQ35983889-74257FEB-641C-424F-A142-034C1B69DF76Q36070199-C48FF62A-661F-4ED3-8BAD-AC8E0EFD2526Q36290277-BF8E0C8C-9B39-4DB7-AE95-B817224692FCQ36373503-7E56D8CF-0EDF-40CF-99E5-DD8B018F9950Q36380337-C24387F0-3B67-40B4-A0B3-1907CC68123DQ36497139-42FF2997-F496-4092-8F3B-665DE898E0B1Q36517090-DF6C61AD-AB71-4EE5-B4F5-9005BD7D308EQ36761513-CB9630E7-A3DD-44DD-AE21-946E1A354FF8Q36920489-43B9BA9B-DF13-4F58-9183-5B3CD7E27595Q37359459-AA5A2D4B-035F-4307-AD1D-E84B0F4D125EQ37582297-D79ABAAC-EB15-47A5-AFDA-5D47495E6D7AQ37619722-21E11D61-BF64-4115-9019-34D309BE23AAQ37678642-8BF5A6B4-51B6-4197-9AF9-6FBEB8A4A839Q37983396-E04D2125-0E1D-4C55-B8F9-DDC40F8A6DECQ38029732-96A64771-8CA2-4FC0-9C28-914402906679Q38089870-54492C52-DBF1-4844-A789-43F4B00BA46DQ38327730-B666FAF0-6670-4188-AD05-EAE6D0E94FACQ38762824-040B61E1-AAF6-42EC-91C9-E9CFF7EC0117Q38814214-6D867AC8-6E87-45C7-879A-B04ACF85B09EQ38885862-AEFB4550-9CBC-4DAB-9A6E-6009A0132D9AQ39031599-87E9C218-D602-42F7-B4DD-4B297C9BACD7Q39755987-2A5EEB12-28BA-4A58-A021-0CB6153B5D68Q40387762-2C59DD0E-D8C9-42B9-88FE-CC65D60E996A
P2860
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Integrative genomic analyses o ...... a biomarker and survival gene
@ast
Integrative genomic analyses o ...... a biomarker and survival gene
@en
type
label
Integrative genomic analyses o ...... a biomarker and survival gene
@ast
Integrative genomic analyses o ...... a biomarker and survival gene
@en
prefLabel
Integrative genomic analyses o ...... a biomarker and survival gene
@ast
Integrative genomic analyses o ...... a biomarker and survival gene
@en
P2093
P2860
P50
P356
P1476
Integrative genomic analyses o ...... a biomarker and survival gene
@en
P2093
Anat Stemmer-Rachamimov
Atira Hardiman
Conxi Lazaro
David Muir
Emily Sites
G Petur Nielsen
Grier Page
Marco Giovannini
P2860
P304
P356
10.1002/EMMM.200900027
P577
2009-07-01T00:00:00Z